Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

White title slide Molecular Tumor Board Mark E. Burkard MD PhD Mary and Rob Gooze Chair in Metastatic Breast Cancer University of Wisconsin- Madison Disclosures M.E.B. declares the following: • Strata Oncology (Medical Advisory Board) • Abbvie, Arcus, Apollomics, Elevation Oncology, Genentech, Puma, Loxo Oncology, Seagen (Research funding) • Novartis, Strata Oncology …
Agenda Subject to Change WVOS 2023 Spring Conference March 24, 2023 Agenda 7:00 AM Registration Open, Breakfast Served & Networking in Resource Center 8:00 AM Welcome & Introductions Ghulam Abbas, MD, FACS President, West Virginia Oncology Society 8:15 AM Clinical Updates on CNS Tumors Sonikpreet Aulakh, MBBS, MD West Virginia University …
SABCS Review Localized Therapy: Updates from a Surgery Perspective March 4, 2023 Anna Weiss MD Associate Professor, Surgery, Medicine University of Rochester, Wilmot Cancer Institute Director, Breast Cancer Service Line, Comprehensive Breast Care Center, Breast Surgery Disclosures ▪ Sponsored research agreement with prior institution, from Myriad Laboratories …
Updates in Triple Negative Breast Cancer Shipra Gandhi, MD Assistant Professor of Oncology Roswell Park Comprehensive Cancer Center Empire State Hematology and Oncology Review of San Antonio Breast Cancer Symposium Disclosures • Consulting - Astrazeneca EARLY - STAGE Role of platinum in TNBC Carboplatin increases pCR rate to >50% with/without …
SABCS Review Localized Therapy: Updates from a Surgery Perspective March 4, 2023 Anna Weiss MD Associate Professor, Surgery, Medicine University of Rochester, Wilmot Cancer Institute Director, Breast Cancer Service Line, Comprehensive Breast Care Center, Breast Surgery Disclosures ▪ Sponsored research agreement with prior institution, from Myriad Laboratories …
ASSOCIATION OF COMMUNITY CANCER CENTERS 1 An Innovative Approach to Navigating Patients Through Cancer Diagnostics ASSOCIATION OF COMMUNITY CANCER CENTERS A s advancements in cancer diagnostics have pro-pelled precision medicine forward, next genera-tion sequencing (NGS) technology has become a popular way to perform multigene testing in patients with cancer.1 …
Marty Makary, MD, MPH, discusses the American healthcare cost crisis, in his keynote address at the North Carolina Oncology Association and South Carolina Oncology Society annual joint conference.
Hormone receptor-positive breast cancer Ruth O’Regan, MD Chair and Charles A. Dewey Professor, Department of Medicine Associate Director for Education and Mentoring, Wilmot Cancer Institute University of Rochester Disclosures I have served as an advisor for PUMA, Lilly, Pfizer, Seagen, Novartis, Astra-Zeneca and have served on DSMB for Gilead All slides included …
Survivorship Update SABCS 2022 Tracey O’Connor, MD Associate Professor of Oncology Roswell Park Comprehensive Cancer Center Disclosures/Conflicts of Interest • None SABCS 2024 Highlights • GS4-09 Pregnancy Outcome and Safety of Interrupting Therapy for women with Endocrine Responsive Breast Cancer: Primary Results from the POSITIVE trial Partridge et al. • …
PowerPoint Presentation ESHOS SABCS 2022 Review: Genomic Update Seth A. Wander, MD, PhD Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital swander@mgh.harvard.edu Disclosures • Consulting/Advisory Board: Biovica, Eli Lilly,Foundation Medicine, Hologic, Pfizer, Puma Biotechnology, Veracyte • Education/Speaking: Eli Lilly, Guardant …
PowerPoint Presentation Review of the San Antonio Breast Cancer Symposium Simon Fung-Kee-Fung, MD March 4, 2023 Localized Therapy: Radiation Oncology Disclosures • None Outline: RT Advances = Less Toxicity • New Fractionation Schemes (A Review) – Early Stage Breast Cancer – PostMastectomy Radiation Therapy • New(ish) Technology – VMAT, Protons oh my! …
Disclosures and Conflict of Interest (COI) Mitigation Faculty, Staff, and Planners’ Disclosures The following individuals have no relevant financial relationships with ineligible companies to disclose: Simon Fung-Kee-Fung, Ruth O’Regan, MD; Rahul Seth, DO; Tracey O’Connor, MD, and the staffs of the Empire State Hematology and Oncology Society and Physicians’ Education Resource®, LLC. Faculty …
1 INTRODUCTION Cancer is the leading cause of mortality for Hispanics, accounting for 22 percent of all deaths. Compared to Non-Hispanic Whites (NHWs), Hispanics are more likely to be diagnosed with advanced stages of disease and experience poor quality of life following a cancer diagnosis. Moreover, Hispanics are significantly less likely to be screened for breast, cervical, and colorectal …
February 27, 2023
ACCC has invited providers across the U.S. to discuss the unique challenges seen in their respective regions and address how the current state of cancer care for patients with chronic lymphocytic leukemia (CLL) may be improved.
February 27, 2023
This webinar will highlight how community cancer programs are using a new approach to optimize biomarker testing processes through the addition of a precision medicine steward. Precision medicine experts will outline strategies and key metrics that demonstrate how precision medicine stewardship can improve coordination and streamline workflows to ensure timely, equitable testing for patients who may …
Hear the most up-to-date best practices, including shared decision-making, regarding treating patients with CLL in this post-COVID era.
* Audited financial statements are available at ACCC’s headquarters. 2022 ACCC Treasurer’s Report Nadine J. Barrett, PhD, MA, MS The statement of financial position shows an increase in net assets of $1,283,624 from $15,619,007 to $16,902,631 for fiscal year 2021 to 2022. The increase is largely due to funding for new educational programming. The statement of activities and change in …